We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PSNL market cap is 414M. The company's latest EPS is USD -1.5329 and P/E is -3.89.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.25M | 19.68M | 19.53M | 22.58M | 25.71M |
| Operating Income | -25.23M | -24.91M | -18.88M | -16.89M | -14.38M |
| Net Income | -29.1M | -26.58M | -12.97M | -12.8M | -39.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 65.21M | 78.65M | 85.49M | 65.05M | 73.48M |
| Operating Income | -22.42M | -42.15M | -65.35M | -115.53M | -104.37M |
| Net Income | -25.08M | -41.28M | -65.23M | -113.32M | -108.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 226.64M | 225.1M | 195.28M | 185.5M | 239.89M |
| Total Liabilities | 75.43M | 95.66M | 74.58M | 73.23M | 73.13M |
| Total Equity | 151.21M | 129.44M | 120.69M | 112.27M | 166.76M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 157.29M | 244.84M | 396.53M | 292.7M | 225.1M |
| Total Liabilities | 50.6M | 49.9M | 86.23M | 74.56M | 95.66M |
| Total Equity | 106.69M | 194.95M | 310.3M | 218.14M | 129.44M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.84M | -56.26M | -20.41M | -31.16M | -37.35M |
| Investing | 24.74M | 13.1M | 6.3M | 19.29M | -8.89M |
| Financing | 1.22M | 11.03M | 1.13M | 2.65M | 65.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.07M | -42.65M | -70.83M | -70.23M | -56.26M |
| Investing | -81.58M | -65.14M | -60.07M | 52.54M | 13.1M |
| Financing | 134.95M | 121.27M | 169.7M | 1.37M | 11.03M |
| Market Cap | 414M |
| Price to Earnings Ratio | -3.89 |
| Price to Sales Ratio | 5.73 |
| Price to Cash Ratio | 7.39 |
| Price to Book Ratio | 3.25 |
| Dividend Yield | - |
| Shares Outstanding | 70.65M |
| Average Volume (1 week) | 3.09M |
| Average Volume (1 Month) | 1.21M |
| 52 Week Change | 285.53% |
| 52 Week High | 7.20 |
| 52 Week Low | 1.12 |
| Spread (Intraday) | 0.24 (3.93%) |
| Company Name | Personalis Inc |
| Address |
3500 south dupont highway dover, delaware 19901 |
| Website | https://www.personalis.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
